Saptalis Pharmaceuticals, LLC — Form D
Saptalis Pharmaceuticals, LLC of HAUPPAUGE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-08. The offering totals $6.5M, of which $6.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-08
- Form: D
- Accession: 0000909012-16-000603
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $6.5M
- Investors: 7
- Date of first sale: 2016-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-274033
Issuer
- Name: Saptalis Pharmaceuticals, LLC
- CIK: 0001646767
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 45 DAVIDS DRIVE, HAUPPAUGE, NY, 11788
- Phone: 631 231 2751
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Tatiana Akimova | Director | Hauppauge, NY |
| Polireddy Dondeti | Director | Hauppauge, NY |
| Tatiana Akimova | Executive Officer | Hauppauge, NY |
| Polireddy Dondeti | Executive Officer | Hauppauge, NY |
Other filings by this issuer (1)
More